Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• WHO COVID-19 Dashboard. Geneva: World Health Organization. 2022; Available from: https://covid19.who.int/.
   Google Scholar
• Plante JA, Mitchell BM, Plante KS, et al. The variant gambit: COVID-19's next move. Cell Host Microbe. 2021 Apr 14;29(4):508–515.
   PubMed Web of Science ®Google Scholar
• Petersen E, Ntoumi F, Hui DS, et al. Emergence of new SARS-CoV-2 variant of concern Omicron (B.1.1.529) – highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2022 Jan;114:268–272.
   PubMed Web of Science ®Google Scholar
• Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021 Dec;600(7887):21–21.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang R, Gilby NB, et al. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022 Jan 24;62(2):412–422.
   PubMed Web of Science ®Google Scholar
• VanBlargan LA, Errico JM, Halfmann PJ, et al. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat Med. 2022 Mar;28(3):490–495.
   PubMed Web of Science ®Google Scholar
• Wolter N, Jassat W, Walaza S, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 Jan 29;399(10323):437–446.
   PubMed Web of Science ®Google Scholar
• Sigal A. Milder disease with Omicron: is it the virus or the pre-existing immunity? Nat Rev Immunol. 2022 Feb;22(2):69–71.
   PubMed Web of Science ®Google Scholar
• Abdelnabi R, Foo CS, Zhang X, et al. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters. Antiviral Res. 2022 Jan 21;198:105253.
   PubMed Web of Science ®Google Scholar
• Halfmann PJ, Iida S, Iwatsuki-Horimoto K, et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature. 2022 Mar;603(7902):687–692.
   PubMed Web of Science ®Google Scholar
• GeurtsvanKessel CH, Geers D, Schmitz KS, et al. Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients. Sci Immunol. 2022 Mar 25;7(69):eabo2202.
   PubMed Web of Science ®Google Scholar
• de Vries RD, Schmitz KS, Bovier FT, et al. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science. 2021 Mar 26;371(6536):1379–1382.
   PubMed Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020 Jan;25(3):2000045.
   PubMedGoogle Scholar
• Lamers MM, Breugem TI, Mykytyn AZ, et al. Human organoid systems reveal in vitro correlates of fitness for SARS-CoV-2 B.1.1.7. bioRxiv. 2021:2021.05.03.441080.
   Google Scholar
• Mykytyn AZ, Rissmann M, Kok A, et al. Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants. bioRxiv. 2022:2022.02.23.481644.
   Google Scholar
• Rockx B, Kuiken T, Herfst S, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020 May 29;368(6494):1012–1015.
   PubMed Web of Science ®Google Scholar
• Sia SF, Yan LM, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020 Jul;583(7818):834–838.
   PubMed Web of Science ®Google Scholar
• Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in Tshwane, South Africa. Int J Infect Dis. 2021 Dec 28;116:38–42.
   PubMed Web of Science ®Google Scholar
• Despres HW, Mills MG, Shirley DJ, et al. Measuring infectious SARS-CoV-2 in clinical samples reveals a higher viral titer: RNA ratio for Delta and Epsilon vs. Alpha variants. Proc Natl Acad Sci U S A. 2022 Feb 1;119(5):e2116518119.
   PubMed Web of Science ®Google Scholar
• Fall A, Eldesouki RE, Sachithanandham J, et al. A quick displacement of the SARS-CoV-2 variant delta with Omicron: unprecedented spike in COVID-19 cases associated with fewer admissions and comparable upper respiratory viral loads. medRxiv. 2022 Jan 28.
   Google Scholar
• Yuan S, Ye Z-W, Liang R, et al. The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model. bioRxiv. 2022:2022.01.12.476031.
   Google Scholar
• Haagmans BL, Noack D, Okba NMA, et al. SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model. J Infect Dis. 2021;223(12):2020–2028.
   PubMed Web of Science ®Google Scholar
• Mykytyn AZ, Breugem TI, Riesebosch S, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. Elife. 2021 Jan 4;10:e64508.
   PubMed Web of Science ®Google Scholar
• Lamers MM, Mykytyn AZ, Breugem TI, et al. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation. Elife. 2021 Apr 9;10:e66815.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Xie X, Bailey AL, et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 Mar;591(7849):293–299.
   PubMed Web of Science ®Google Scholar
• Lau SY, Wang P, Mok BW, et al. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. Emerg Microbes Infect. 2020 Dec;9(1):837–842.
   PubMed Web of Science ®Google Scholar
• Meng B, Abdullahi A, Ferreira IATM, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022 2022/03/01;603(7902):706–714.
   PubMed Web of Science ®Google Scholar
• Lamers MM, Mykytyn AZ, Breugem TI, et al. SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium. bioRxiv. 2022:2022.01.19.476898.
   Google Scholar
• Uraki R, Kiso M, Iida S, et al. Characterization and antiviral susceptibility of SARS-CoV-2 omicron/BA.2. Nature. 2022/05/16;2022.
   Google Scholar
• Wei C, Shan KJ, Wang W, et al. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J Genet Genomics. 2021 Dec;48(12):1111–1121.
   PubMed Web of Science ®Google Scholar
• Hansen F, Meade-White K, Clancy C, et al. SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract. Cell Rep. 2022 Mar 15;38(11):110515.
   PubMed Web of Science ®Google Scholar